Global Butylscopolamine Bromide Market Growth (Status and Outlook) 2025-2031
According to this study, the global Butylscopolamine Bromide market size will reach US$ million by 2031.
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
United States market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Butylscopolamine Bromide players cover Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Butylscopolamine Bromide Industry Forecast” looks at past sales and reviews total world Butylscopolamine Bromide sales in 2024, providing a comprehensive analysis by region and market sector of projected Butylscopolamine Bromide sales for 2025 through 2031. With Butylscopolamine Bromide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Butylscopolamine Bromide industry.
This Insight Report provides a comprehensive analysis of the global Butylscopolamine Bromide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Butylscopolamine Bromide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Butylscopolamine Bromide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Butylscopolamine Bromide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Butylscopolamine Bromide.
This report presents a comprehensive overview, market shares, and growth opportunities of Butylscopolamine Bromide market by product type, application, key players and key regions and countries.
Segmentation by Type:
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
United States market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Butylscopolamine Bromide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Butylscopolamine Bromide players cover Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Butylscopolamine Bromide Industry Forecast” looks at past sales and reviews total world Butylscopolamine Bromide sales in 2024, providing a comprehensive analysis by region and market sector of projected Butylscopolamine Bromide sales for 2025 through 2031. With Butylscopolamine Bromide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Butylscopolamine Bromide industry.
This Insight Report provides a comprehensive analysis of the global Butylscopolamine Bromide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Butylscopolamine Bromide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Butylscopolamine Bromide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Butylscopolamine Bromide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Butylscopolamine Bromide.
This report presents a comprehensive overview, market shares, and growth opportunities of Butylscopolamine Bromide market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Tablets
- Capsule
- Intramuscular Injection
- Intravenous Or Drip
- Suppositories
- Other
- Stomach
- Gas Barium Hypography
- Abdominal CT Scan
- Gastrointestinal Spasm
- Biliary Colic
- Renal Colic
- Gastrointestinal Hypermotility
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Boehringer Ingelheim
- Sandoz (Novartis)
- Boehringer Ingelheim Pharma GmbH & Co. KG
- XI AN TIANXINGJIAN PHARMCHEM
- Linnea
- Alkaloida
- Chengdu Tiantaishan Pharmaceutical
- Jiangsu Ange Pharmaceutical
- Chengdu First Pharmaceutical
- Beijing Zizhu Pharmaceutical
- Guangdong Zhongsheng Pharmaceutical
- Wanbangde Pharmaceutical Group
- Shandong Yijian Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Butylscopolamine Bromide Market Size (2020-2031)
2.1.2 Butylscopolamine Bromide Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Butylscopolamine Bromide by Country/Region (2020, 2024 & 2031)
2.2 Butylscopolamine Bromide Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Intramuscular Injection
2.2.4 Intravenous Or Drip
2.2.5 Suppositories
2.2.6 Other
2.3 Butylscopolamine Bromide Market Size by Type
2.3.1 Butylscopolamine Bromide Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
2.4 Butylscopolamine Bromide Segment by Application
2.4.1 Stomach
2.4.2 Gas Barium Hypography
2.4.3 Abdominal CT Scan
2.4.4 Gastrointestinal Spasm
2.4.5 Biliary Colic
2.4.6 Renal Colic
2.4.7 Gastrointestinal Hypermotility
2.4.8 Other
2.5 Butylscopolamine Bromide Market Size by Application
2.5.1 Butylscopolamine Bromide Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
3 BUTYLSCOPOLAMINE BROMIDE MARKET SIZE BY PLAYER
3.1 Butylscopolamine Bromide Market Size Market Share by Player
3.1.1 Global Butylscopolamine Bromide Revenue by Player (2020-2025)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Player (2020-2025)
3.2 Global Butylscopolamine Bromide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BUTYLSCOPOLAMINE BROMIDE BY REGION
4.1 Butylscopolamine Bromide Market Size by Region (2020-2025)
4.2 Global Butylscopolamine Bromide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Butylscopolamine Bromide Market Size Growth (2020-2025)
4.4 APAC Butylscopolamine Bromide Market Size Growth (2020-2025)
4.5 Europe Butylscopolamine Bromide Market Size Growth (2020-2025)
4.6 Middle East & Africa Butylscopolamine Bromide Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Butylscopolamine Bromide Market Size by Country (2020-2025)
5.2 Americas Butylscopolamine Bromide Market Size by Type (2020-2025)
5.3 Americas Butylscopolamine Bromide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Butylscopolamine Bromide Market Size by Region (2020-2025)
6.2 APAC Butylscopolamine Bromide Market Size by Type (2020-2025)
6.3 APAC Butylscopolamine Bromide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Butylscopolamine Bromide Market Size by Country (2020-2025)
7.2 Europe Butylscopolamine Bromide Market Size by Type (2020-2025)
7.3 Europe Butylscopolamine Bromide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Butylscopolamine Bromide by Region (2020-2025)
8.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2020-2025)
8.3 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BUTYLSCOPOLAMINE BROMIDE MARKET FORECAST
10.1 Global Butylscopolamine Bromide Forecast by Region (2026-2031)
10.1.1 Global Butylscopolamine Bromide Forecast by Region (2026-2031)
10.1.2 Americas Butylscopolamine Bromide Forecast
10.1.3 APAC Butylscopolamine Bromide Forecast
10.1.4 Europe Butylscopolamine Bromide Forecast
10.1.5 Middle East & Africa Butylscopolamine Bromide Forecast
10.2 Americas Butylscopolamine Bromide Forecast by Country (2026-2031)
10.2.1 United States Market Butylscopolamine Bromide Forecast
10.2.2 Canada Market Butylscopolamine Bromide Forecast
10.2.3 Mexico Market Butylscopolamine Bromide Forecast
10.2.4 Brazil Market Butylscopolamine Bromide Forecast
10.3 APAC Butylscopolamine Bromide Forecast by Region (2026-2031)
10.3.1 China Butylscopolamine Bromide Market Forecast
10.3.2 Japan Market Butylscopolamine Bromide Forecast
10.3.3 Korea Market Butylscopolamine Bromide Forecast
10.3.4 Southeast Asia Market Butylscopolamine Bromide Forecast
10.3.5 India Market Butylscopolamine Bromide Forecast
10.3.6 Australia Market Butylscopolamine Bromide Forecast
10.4 Europe Butylscopolamine Bromide Forecast by Country (2026-2031)
10.4.1 Germany Market Butylscopolamine Bromide Forecast
10.4.2 France Market Butylscopolamine Bromide Forecast
10.4.3 UK Market Butylscopolamine Bromide Forecast
10.4.4 Italy Market Butylscopolamine Bromide Forecast
10.4.5 Russia Market Butylscopolamine Bromide Forecast
10.5 Middle East & Africa Butylscopolamine Bromide Forecast by Region (2026-2031)
10.5.1 Egypt Market Butylscopolamine Bromide Forecast
10.5.2 South Africa Market Butylscopolamine Bromide Forecast
10.5.3 Israel Market Butylscopolamine Bromide Forecast
10.5.4 Turkey Market Butylscopolamine Bromide Forecast
10.6 Global Butylscopolamine Bromide Forecast by Type (2026-2031)
10.7 Global Butylscopolamine Bromide Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Butylscopolamine Bromide Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Butylscopolamine Bromide Product Offered
11.1.3 Sanofi Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Butylscopolamine Bromide Product Offered
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Butylscopolamine Bromide Product Offered
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Information
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product Offered
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Main Business Overview
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Latest Developments
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Information
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product Offered
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Main Business Overview
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Latest Developments
11.6 Linnea
11.6.1 Linnea Company Information
11.6.2 Linnea Butylscopolamine Bromide Product Offered
11.6.3 Linnea Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Linnea Main Business Overview
11.6.5 Linnea Latest Developments
11.7 Alkaloida
11.7.1 Alkaloida Company Information
11.7.2 Alkaloida Butylscopolamine Bromide Product Offered
11.7.3 Alkaloida Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Alkaloida Main Business Overview
11.7.5 Alkaloida Latest Developments
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Information
11.8.2 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product Offered
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Chengdu Tiantaishan Pharmaceutical Main Business Overview
11.8.5 Chengdu Tiantaishan Pharmaceutical Latest Developments
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Information
11.9.2 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product Offered
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jiangsu Ange Pharmaceutical Main Business Overview
11.9.5 Jiangsu Ange Pharmaceutical Latest Developments
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Information
11.10.2 Chengdu First Pharmaceutical Butylscopolamine Bromide Product Offered
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Chengdu First Pharmaceutical Main Business Overview
11.10.5 Chengdu First Pharmaceutical Latest Developments
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Information
11.11.2 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product Offered
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Beijing Zizhu Pharmaceutical Main Business Overview
11.11.5 Beijing Zizhu Pharmaceutical Latest Developments
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Information
11.12.2 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product Offered
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
11.12.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Information
11.13.2 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product Offered
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Wanbangde Pharmaceutical Group Main Business Overview
11.13.5 Wanbangde Pharmaceutical Group Latest Developments
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Information
11.14.2 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product Offered
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Shandong Yijian Pharmaceutical Main Business Overview
11.14.5 Shandong Yijian Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Butylscopolamine Bromide Market Size (2020-2031)
2.1.2 Butylscopolamine Bromide Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Butylscopolamine Bromide by Country/Region (2020, 2024 & 2031)
2.2 Butylscopolamine Bromide Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Intramuscular Injection
2.2.4 Intravenous Or Drip
2.2.5 Suppositories
2.2.6 Other
2.3 Butylscopolamine Bromide Market Size by Type
2.3.1 Butylscopolamine Bromide Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
2.4 Butylscopolamine Bromide Segment by Application
2.4.1 Stomach
2.4.2 Gas Barium Hypography
2.4.3 Abdominal CT Scan
2.4.4 Gastrointestinal Spasm
2.4.5 Biliary Colic
2.4.6 Renal Colic
2.4.7 Gastrointestinal Hypermotility
2.4.8 Other
2.5 Butylscopolamine Bromide Market Size by Application
2.5.1 Butylscopolamine Bromide Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
3 BUTYLSCOPOLAMINE BROMIDE MARKET SIZE BY PLAYER
3.1 Butylscopolamine Bromide Market Size Market Share by Player
3.1.1 Global Butylscopolamine Bromide Revenue by Player (2020-2025)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Player (2020-2025)
3.2 Global Butylscopolamine Bromide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BUTYLSCOPOLAMINE BROMIDE BY REGION
4.1 Butylscopolamine Bromide Market Size by Region (2020-2025)
4.2 Global Butylscopolamine Bromide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Butylscopolamine Bromide Market Size Growth (2020-2025)
4.4 APAC Butylscopolamine Bromide Market Size Growth (2020-2025)
4.5 Europe Butylscopolamine Bromide Market Size Growth (2020-2025)
4.6 Middle East & Africa Butylscopolamine Bromide Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Butylscopolamine Bromide Market Size by Country (2020-2025)
5.2 Americas Butylscopolamine Bromide Market Size by Type (2020-2025)
5.3 Americas Butylscopolamine Bromide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Butylscopolamine Bromide Market Size by Region (2020-2025)
6.2 APAC Butylscopolamine Bromide Market Size by Type (2020-2025)
6.3 APAC Butylscopolamine Bromide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Butylscopolamine Bromide Market Size by Country (2020-2025)
7.2 Europe Butylscopolamine Bromide Market Size by Type (2020-2025)
7.3 Europe Butylscopolamine Bromide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Butylscopolamine Bromide by Region (2020-2025)
8.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2020-2025)
8.3 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BUTYLSCOPOLAMINE BROMIDE MARKET FORECAST
10.1 Global Butylscopolamine Bromide Forecast by Region (2026-2031)
10.1.1 Global Butylscopolamine Bromide Forecast by Region (2026-2031)
10.1.2 Americas Butylscopolamine Bromide Forecast
10.1.3 APAC Butylscopolamine Bromide Forecast
10.1.4 Europe Butylscopolamine Bromide Forecast
10.1.5 Middle East & Africa Butylscopolamine Bromide Forecast
10.2 Americas Butylscopolamine Bromide Forecast by Country (2026-2031)
10.2.1 United States Market Butylscopolamine Bromide Forecast
10.2.2 Canada Market Butylscopolamine Bromide Forecast
10.2.3 Mexico Market Butylscopolamine Bromide Forecast
10.2.4 Brazil Market Butylscopolamine Bromide Forecast
10.3 APAC Butylscopolamine Bromide Forecast by Region (2026-2031)
10.3.1 China Butylscopolamine Bromide Market Forecast
10.3.2 Japan Market Butylscopolamine Bromide Forecast
10.3.3 Korea Market Butylscopolamine Bromide Forecast
10.3.4 Southeast Asia Market Butylscopolamine Bromide Forecast
10.3.5 India Market Butylscopolamine Bromide Forecast
10.3.6 Australia Market Butylscopolamine Bromide Forecast
10.4 Europe Butylscopolamine Bromide Forecast by Country (2026-2031)
10.4.1 Germany Market Butylscopolamine Bromide Forecast
10.4.2 France Market Butylscopolamine Bromide Forecast
10.4.3 UK Market Butylscopolamine Bromide Forecast
10.4.4 Italy Market Butylscopolamine Bromide Forecast
10.4.5 Russia Market Butylscopolamine Bromide Forecast
10.5 Middle East & Africa Butylscopolamine Bromide Forecast by Region (2026-2031)
10.5.1 Egypt Market Butylscopolamine Bromide Forecast
10.5.2 South Africa Market Butylscopolamine Bromide Forecast
10.5.3 Israel Market Butylscopolamine Bromide Forecast
10.5.4 Turkey Market Butylscopolamine Bromide Forecast
10.6 Global Butylscopolamine Bromide Forecast by Type (2026-2031)
10.7 Global Butylscopolamine Bromide Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Butylscopolamine Bromide Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Butylscopolamine Bromide Product Offered
11.1.3 Sanofi Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Butylscopolamine Bromide Product Offered
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Butylscopolamine Bromide Product Offered
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Information
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product Offered
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Main Business Overview
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Latest Developments
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Information
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product Offered
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Main Business Overview
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Latest Developments
11.6 Linnea
11.6.1 Linnea Company Information
11.6.2 Linnea Butylscopolamine Bromide Product Offered
11.6.3 Linnea Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Linnea Main Business Overview
11.6.5 Linnea Latest Developments
11.7 Alkaloida
11.7.1 Alkaloida Company Information
11.7.2 Alkaloida Butylscopolamine Bromide Product Offered
11.7.3 Alkaloida Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Alkaloida Main Business Overview
11.7.5 Alkaloida Latest Developments
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Information
11.8.2 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product Offered
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Chengdu Tiantaishan Pharmaceutical Main Business Overview
11.8.5 Chengdu Tiantaishan Pharmaceutical Latest Developments
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Information
11.9.2 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product Offered
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jiangsu Ange Pharmaceutical Main Business Overview
11.9.5 Jiangsu Ange Pharmaceutical Latest Developments
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Information
11.10.2 Chengdu First Pharmaceutical Butylscopolamine Bromide Product Offered
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Chengdu First Pharmaceutical Main Business Overview
11.10.5 Chengdu First Pharmaceutical Latest Developments
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Information
11.11.2 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product Offered
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Beijing Zizhu Pharmaceutical Main Business Overview
11.11.5 Beijing Zizhu Pharmaceutical Latest Developments
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Information
11.12.2 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product Offered
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
11.12.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Information
11.13.2 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product Offered
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Wanbangde Pharmaceutical Group Main Business Overview
11.13.5 Wanbangde Pharmaceutical Group Latest Developments
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Information
11.14.2 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product Offered
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Shandong Yijian Pharmaceutical Main Business Overview
11.14.5 Shandong Yijian Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Butylscopolamine Bromide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Butylscopolamine Bromide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsule
Table 5. Major Players of Intramuscular Injection
Table 6. Major Players of Intravenous Or Drip
Table 7. Major Players of Suppositories
Table 8. Major Players of Other
Table 9. Butylscopolamine Bromide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Table 12. Butylscopolamine Bromide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Table 15. Global Butylscopolamine Bromide Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Butylscopolamine Bromide Revenue Market Share by Player (2020-2025)
Table 17. Butylscopolamine Bromide Key Players Head office and Products Offered
Table 18. Butylscopolamine Bromide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Table 23. Global Butylscopolamine Bromide Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Butylscopolamine Bromide Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Butylscopolamine Bromide Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Butylscopolamine Bromide Market Size Market Share by Country (2020-2025)
Table 27. Americas Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Table 29. Americas Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Table 31. APAC Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Table 33. APAC Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Butylscopolamine Bromide Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Butylscopolamine Bromide Market Size Market Share by Country (2020-2025)
Table 37. Europe Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Butylscopolamine Bromide
Table 43. Key Market Challenges & Risks of Butylscopolamine Bromide
Table 44. Key Industry Trends of Butylscopolamine Bromide
Table 45. Global Butylscopolamine Bromide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Butylscopolamine Bromide Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Butylscopolamine Bromide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Butylscopolamine Bromide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Sanofi Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 50. Sanofi Butylscopolamine Bromide Product Offered
Table 51. Sanofi Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Sanofi Main Business
Table 53. Sanofi Latest Developments
Table 54. Boehringer Ingelheim Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 55. Boehringer Ingelheim Butylscopolamine Bromide Product Offered
Table 56. Boehringer Ingelheim Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Boehringer Ingelheim Main Business
Table 58. Boehringer Ingelheim Latest Developments
Table 59. Sandoz (Novartis) Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 60. Sandoz (Novartis) Butylscopolamine Bromide Product Offered
Table 61. Sandoz (Novartis) Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Sandoz (Novartis) Main Business
Table 63. Sandoz (Novartis) Latest Developments
Table 64. Boehringer Ingelheim Pharma GmbH & Co. KG Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 65. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product Offered
Table 66. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Boehringer Ingelheim Pharma GmbH & Co. KG Main Business
Table 68. Boehringer Ingelheim Pharma GmbH & Co. KG Latest Developments
Table 69. XI AN TIANXINGJIAN PHARMCHEM Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 70. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product Offered
Table 71. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. XI AN TIANXINGJIAN PHARMCHEM Main Business
Table 73. XI AN TIANXINGJIAN PHARMCHEM Latest Developments
Table 74. Linnea Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 75. Linnea Butylscopolamine Bromide Product Offered
Table 76. Linnea Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Linnea Main Business
Table 78. Linnea Latest Developments
Table 79. Alkaloida Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 80. Alkaloida Butylscopolamine Bromide Product Offered
Table 81. Alkaloida Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Alkaloida Main Business
Table 83. Alkaloida Latest Developments
Table 84. Chengdu Tiantaishan Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 85. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product Offered
Table 86. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Chengdu Tiantaishan Pharmaceutical Main Business
Table 88. Chengdu Tiantaishan Pharmaceutical Latest Developments
Table 89. Jiangsu Ange Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 90. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product Offered
Table 91. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Jiangsu Ange Pharmaceutical Main Business
Table 93. Jiangsu Ange Pharmaceutical Latest Developments
Table 94. Chengdu First Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 95. Chengdu First Pharmaceutical Butylscopolamine Bromide Product Offered
Table 96. Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Chengdu First Pharmaceutical Main Business
Table 98. Chengdu First Pharmaceutical Latest Developments
Table 99. Beijing Zizhu Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 100. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product Offered
Table 101. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Beijing Zizhu Pharmaceutical Main Business
Table 103. Beijing Zizhu Pharmaceutical Latest Developments
Table 104. Guangdong Zhongsheng Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 105. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product Offered
Table 106. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Guangdong Zhongsheng Pharmaceutical Main Business
Table 108. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 109. Wanbangde Pharmaceutical Group Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 110. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product Offered
Table 111. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Wanbangde Pharmaceutical Group Main Business
Table 113. Wanbangde Pharmaceutical Group Latest Developments
Table 114. Shandong Yijian Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 115. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product Offered
Table 116. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Shandong Yijian Pharmaceutical Main Business
Table 118. Shandong Yijian Pharmaceutical Latest Developments
Table 1. Butylscopolamine Bromide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Butylscopolamine Bromide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsule
Table 5. Major Players of Intramuscular Injection
Table 6. Major Players of Intravenous Or Drip
Table 7. Major Players of Suppositories
Table 8. Major Players of Other
Table 9. Butylscopolamine Bromide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Table 12. Butylscopolamine Bromide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Table 15. Global Butylscopolamine Bromide Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Butylscopolamine Bromide Revenue Market Share by Player (2020-2025)
Table 17. Butylscopolamine Bromide Key Players Head office and Products Offered
Table 18. Butylscopolamine Bromide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Table 23. Global Butylscopolamine Bromide Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Butylscopolamine Bromide Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Butylscopolamine Bromide Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Butylscopolamine Bromide Market Size Market Share by Country (2020-2025)
Table 27. Americas Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Table 29. Americas Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Table 31. APAC Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Table 33. APAC Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Butylscopolamine Bromide Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Butylscopolamine Bromide Market Size Market Share by Country (2020-2025)
Table 37. Europe Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Butylscopolamine Bromide Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Butylscopolamine Bromide Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Butylscopolamine Bromide Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Butylscopolamine Bromide
Table 43. Key Market Challenges & Risks of Butylscopolamine Bromide
Table 44. Key Industry Trends of Butylscopolamine Bromide
Table 45. Global Butylscopolamine Bromide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Butylscopolamine Bromide Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Butylscopolamine Bromide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Butylscopolamine Bromide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Sanofi Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 50. Sanofi Butylscopolamine Bromide Product Offered
Table 51. Sanofi Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Sanofi Main Business
Table 53. Sanofi Latest Developments
Table 54. Boehringer Ingelheim Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 55. Boehringer Ingelheim Butylscopolamine Bromide Product Offered
Table 56. Boehringer Ingelheim Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Boehringer Ingelheim Main Business
Table 58. Boehringer Ingelheim Latest Developments
Table 59. Sandoz (Novartis) Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 60. Sandoz (Novartis) Butylscopolamine Bromide Product Offered
Table 61. Sandoz (Novartis) Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Sandoz (Novartis) Main Business
Table 63. Sandoz (Novartis) Latest Developments
Table 64. Boehringer Ingelheim Pharma GmbH & Co. KG Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 65. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product Offered
Table 66. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Boehringer Ingelheim Pharma GmbH & Co. KG Main Business
Table 68. Boehringer Ingelheim Pharma GmbH & Co. KG Latest Developments
Table 69. XI AN TIANXINGJIAN PHARMCHEM Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 70. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product Offered
Table 71. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. XI AN TIANXINGJIAN PHARMCHEM Main Business
Table 73. XI AN TIANXINGJIAN PHARMCHEM Latest Developments
Table 74. Linnea Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 75. Linnea Butylscopolamine Bromide Product Offered
Table 76. Linnea Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Linnea Main Business
Table 78. Linnea Latest Developments
Table 79. Alkaloida Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 80. Alkaloida Butylscopolamine Bromide Product Offered
Table 81. Alkaloida Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Alkaloida Main Business
Table 83. Alkaloida Latest Developments
Table 84. Chengdu Tiantaishan Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 85. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product Offered
Table 86. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Chengdu Tiantaishan Pharmaceutical Main Business
Table 88. Chengdu Tiantaishan Pharmaceutical Latest Developments
Table 89. Jiangsu Ange Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 90. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product Offered
Table 91. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Jiangsu Ange Pharmaceutical Main Business
Table 93. Jiangsu Ange Pharmaceutical Latest Developments
Table 94. Chengdu First Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 95. Chengdu First Pharmaceutical Butylscopolamine Bromide Product Offered
Table 96. Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Chengdu First Pharmaceutical Main Business
Table 98. Chengdu First Pharmaceutical Latest Developments
Table 99. Beijing Zizhu Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 100. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product Offered
Table 101. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. Beijing Zizhu Pharmaceutical Main Business
Table 103. Beijing Zizhu Pharmaceutical Latest Developments
Table 104. Guangdong Zhongsheng Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 105. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product Offered
Table 106. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Guangdong Zhongsheng Pharmaceutical Main Business
Table 108. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 109. Wanbangde Pharmaceutical Group Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 110. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product Offered
Table 111. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. Wanbangde Pharmaceutical Group Main Business
Table 113. Wanbangde Pharmaceutical Group Latest Developments
Table 114. Shandong Yijian Pharmaceutical Details, Company Type, Butylscopolamine Bromide Area Served and Its Competitors
Table 115. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product Offered
Table 116. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Shandong Yijian Pharmaceutical Main Business
Table 118. Shandong Yijian Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Butylscopolamine Bromide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Butylscopolamine Bromide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Butylscopolamine Bromide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Butylscopolamine Bromide Sales Market Share by Country/Region (2024)
Figure 8. Butylscopolamine Bromide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Butylscopolamine Bromide Market Size Market Share by Type in 2024
Figure 10. Butylscopolamine Bromide in Stomach
Figure 11. Global Butylscopolamine Bromide Market: Stomach (2020-2025) & ($ millions)
Figure 12. Butylscopolamine Bromide in Gas Barium Hypography
Figure 13. Global Butylscopolamine Bromide Market: Gas Barium Hypography (2020-2025) & ($ millions)
Figure 14. Butylscopolamine Bromide in Abdominal CT Scan
Figure 15. Global Butylscopolamine Bromide Market: Abdominal CT Scan (2020-2025) & ($ millions)
Figure 16. Butylscopolamine Bromide in Gastrointestinal Spasm
Figure 17. Global Butylscopolamine Bromide Market: Gastrointestinal Spasm (2020-2025) & ($ millions)
Figure 18. Butylscopolamine Bromide in Biliary Colic
Figure 19. Global Butylscopolamine Bromide Market: Biliary Colic (2020-2025) & ($ millions)
Figure 20. Butylscopolamine Bromide in Renal Colic
Figure 21. Global Butylscopolamine Bromide Market: Renal Colic (2020-2025) & ($ millions)
Figure 22. Butylscopolamine Bromide in Gastrointestinal Hypermotility
Figure 23. Global Butylscopolamine Bromide Market: Gastrointestinal Hypermotility (2020-2025) & ($ millions)
Figure 24. Butylscopolamine Bromide in Other
Figure 25. Global Butylscopolamine Bromide Market: Other (2020-2025) & ($ millions)
Figure 26. Global Butylscopolamine Bromide Market Size Market Share by Application in 2024
Figure 27. Global Butylscopolamine Bromide Revenue Market Share by Player in 2024
Figure 28. Global Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Figure 29. Americas Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 30. APAC Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 31. Europe Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 33. Americas Butylscopolamine Bromide Value Market Share by Country in 2024
Figure 34. United States Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Butylscopolamine Bromide Market Size Market Share by Region in 2024
Figure 39. APAC Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 40. APAC Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 41. China Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 45. India Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Butylscopolamine Bromide Market Size Market Share by Country in 2024
Figure 48. Europe Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 49. Europe Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 50. Germany Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 51. France Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 64. APAC Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 65. Europe Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 67. United States Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 68. Canada Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 69. Mexico Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 70. Brazil Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 71. China Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 72. Japan Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 73. Korea Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 75. India Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 76. Australia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 77. Germany Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 78. France Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 79. UK Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 80. Italy Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 81. Russia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 82. Egypt Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 83. South Africa Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 84. Israel Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 85. Turkey Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 86. Global Butylscopolamine Bromide Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Butylscopolamine Bromide Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 1. Butylscopolamine Bromide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Butylscopolamine Bromide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Butylscopolamine Bromide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Butylscopolamine Bromide Sales Market Share by Country/Region (2024)
Figure 8. Butylscopolamine Bromide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Butylscopolamine Bromide Market Size Market Share by Type in 2024
Figure 10. Butylscopolamine Bromide in Stomach
Figure 11. Global Butylscopolamine Bromide Market: Stomach (2020-2025) & ($ millions)
Figure 12. Butylscopolamine Bromide in Gas Barium Hypography
Figure 13. Global Butylscopolamine Bromide Market: Gas Barium Hypography (2020-2025) & ($ millions)
Figure 14. Butylscopolamine Bromide in Abdominal CT Scan
Figure 15. Global Butylscopolamine Bromide Market: Abdominal CT Scan (2020-2025) & ($ millions)
Figure 16. Butylscopolamine Bromide in Gastrointestinal Spasm
Figure 17. Global Butylscopolamine Bromide Market: Gastrointestinal Spasm (2020-2025) & ($ millions)
Figure 18. Butylscopolamine Bromide in Biliary Colic
Figure 19. Global Butylscopolamine Bromide Market: Biliary Colic (2020-2025) & ($ millions)
Figure 20. Butylscopolamine Bromide in Renal Colic
Figure 21. Global Butylscopolamine Bromide Market: Renal Colic (2020-2025) & ($ millions)
Figure 22. Butylscopolamine Bromide in Gastrointestinal Hypermotility
Figure 23. Global Butylscopolamine Bromide Market: Gastrointestinal Hypermotility (2020-2025) & ($ millions)
Figure 24. Butylscopolamine Bromide in Other
Figure 25. Global Butylscopolamine Bromide Market: Other (2020-2025) & ($ millions)
Figure 26. Global Butylscopolamine Bromide Market Size Market Share by Application in 2024
Figure 27. Global Butylscopolamine Bromide Revenue Market Share by Player in 2024
Figure 28. Global Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Figure 29. Americas Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 30. APAC Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 31. Europe Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Butylscopolamine Bromide Market Size 2020-2025 ($ millions)
Figure 33. Americas Butylscopolamine Bromide Value Market Share by Country in 2024
Figure 34. United States Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Butylscopolamine Bromide Market Size Market Share by Region in 2024
Figure 39. APAC Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 40. APAC Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 41. China Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 45. India Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Butylscopolamine Bromide Market Size Market Share by Country in 2024
Figure 48. Europe Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 49. Europe Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 50. Germany Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 51. France Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Butylscopolamine Bromide Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Butylscopolamine Bromide Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 64. APAC Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 65. Europe Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 67. United States Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 68. Canada Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 69. Mexico Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 70. Brazil Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 71. China Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 72. Japan Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 73. Korea Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 75. India Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 76. Australia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 77. Germany Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 78. France Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 79. UK Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 80. Italy Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 81. Russia Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 82. Egypt Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 83. South Africa Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 84. Israel Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 85. Turkey Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
Figure 86. Global Butylscopolamine Bromide Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Butylscopolamine Bromide Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Butylscopolamine Bromide Market Size 2026-2031 ($ millions)
More Publications
Global 3D Cell Culture Market Growth 2025-2031
US$ 3,660.00
March 2025
106 pages
Global Hydrocolloid Tape Market Growth 2024-2030
US$ 3,660.00
December 2024
93 pages
Global Smart Pills Drug Delivery Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
January 2026
85 pages
Global Disposable Hemoperfusion Market Growth 2025-2031
US$ 3,660.00
March 2025
104 pages
Global Effective Microorganisms (EM) Market Growth 2025-2031
US$ 3,660.00
December 2024
103 pages